These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 855730)
1. Hypertriglyceridaemia and chenodeoxycholic acid. Marcolongo R; Debolini A Adv Exp Med Biol; 1977; 76A():557-62. PubMed ID: 855730 [No Abstract] [Full Text] [Related]
2. Chenodeoxycholic acid for hypertriglyceridaemia. Bateson MC Lancet; 1976 Oct; 2(7992):962-3. PubMed ID: 62188 [No Abstract] [Full Text] [Related]
3. The hypotriglyceridemic effect of chenodeoxycholic acid in type IV hyperlipemia. Camarri E; Marcolongo R; Zaccherotti L; Marini G Biomedicine; 1978 Oct; 29(6):193-8. PubMed ID: 216433 [TBL] [Abstract][Full Text] [Related]
4. Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. Bateson MC; Maclean D; Evans JR; Bouchier IA Br J Clin Pharmacol; 1978 Mar; 5(3):249-54. PubMed ID: 656270 [TBL] [Abstract][Full Text] [Related]
5. Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. Miller NE; Nestel PJ Lancet; 1974 Oct; 2(7886):929-31. PubMed ID: 4138590 [No Abstract] [Full Text] [Related]
6. Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration. Camarri E; Marcolongo R; Fici F Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):527-8. PubMed ID: 365797 [TBL] [Abstract][Full Text] [Related]
7. Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia. Camarri E; Fici F; Marcolongo R Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):523-6. PubMed ID: 365796 [TBL] [Abstract][Full Text] [Related]
10. [Results and prospects of therapy of type IV dyslipidemia with chenic acid]. Camarri E; Marcolongo R; Marini G; Zaccherotti L Minerva Med; 1978 May; 69(23):1561-74. PubMed ID: 210428 [TBL] [Abstract][Full Text] [Related]
11. Gout and hyperlipidaemia. Gibson T; Grahame R Ann Rheum Dis; 1974 Jul; 33(4):298-303. PubMed ID: 4413595 [No Abstract] [Full Text] [Related]
12. [The effect of benzbromarone on hyperlipidemia in gout]. Marinchev L; Kŭnev K Vutr Boles; 1990; 29(5):99-102. PubMed ID: 2080622 [TBL] [Abstract][Full Text] [Related]
13. Hyperlipoproteinaemia in gout. Bluestone R; Lewis B; Mervart I Ann Rheum Dis; 1971 Mar; 30(2):134-7. PubMed ID: 5569433 [No Abstract] [Full Text] [Related]
14. Mechanism and treatment of hypertriglyceridaemia in gout. Gibson T; Kilbourn K; Horner I; Simmonds HA Ann Rheum Dis; 1979 Feb; 38(1):31-5. PubMed ID: 434944 [TBL] [Abstract][Full Text] [Related]
15. Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. Bell GD; Lewis B; Petrie A; Dowling RH Br Med J; 1973 Sep; 3(5879):520-3. PubMed ID: 4741607 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex]. Loizzi P; Terlizzi N Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507 [No Abstract] [Full Text] [Related]
17. Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones. Bateson MC; Ross PE; Murison J; Bouchier IA Gut; 1977 Aug; 18(8):599-605. PubMed ID: 330352 [TBL] [Abstract][Full Text] [Related]
18. Gout and hyperlipidaemia. Effect of overweight on the levels of circulating lipids. Rondier J; Truffert J; le Gô A; Cayla J; Hila A; de Gennes JL; Delbarre F Ann Clin Res; 1977 Aug; 9(4):239-45. PubMed ID: 616208 [TBL] [Abstract][Full Text] [Related]